About Ambra Bio
Ambra Bio is a company based in San Diego (United States) founded in 2014. Ambra Bio has raised $1.82 million across 4 funding rounds. Ambra Bio operates in a competitive market with competitors including Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ambra Bioscience Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.82 M (USD)
in 4 rounds
-
Latest Funding Round
$1.05 M (USD), Debt – Conventional
Dec 11, 2017
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ambra Bio
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Ambra Bio
Ambra Bio has successfully raised a total of $1.82M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.05 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Debt – Conventional — $1.1M
-
First Round
First Round
(16 Jan 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2017 | Amount | Debt – Conventional - Ambra Bio | Valuation |
investors |
|
| May, 2017 | Amount | Debt – Conventional - Ambra Bio | Valuation |
investors |
|
| Sep, 2016 | Amount | Seed - Ambra Bio | Valuation |
investors |
|
Investments & Acquisitions by Ambra Bio
Financial Statements - Ambra Bio
Ambra Bio Comparisons
Competitors of Ambra Bio
Ambra Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Natural extract products for immune-mediated diseases are provided.
|
|
| domain | founded_year | HQ Location |
Medical foods are developed using nutrigenomics and bioinformatics models.
|
|
| domain | founded_year | HQ Location |
Therapeutics and medical foods are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Medical foods for digestive disorders are developed and produced.
|
|
| domain | founded_year | HQ Location |
Customized early-life nutrition meals are delivered biweekly to homes.
|
Latest news on Ambra Bio
Frequently Asked Questions about Ambra Bio
Ambra Bio was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Ambra Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Ambra Bio is a funded company, having raised a total of $1.82M across 4 funding rounds to date. The company's 1st funding round was a Seed of $650K, raised on Jan 16, 2015.
Ambra Bio was founded in 2014 in San Diego, United States, within the biotechnology sector focused on health products. Dietary supplements and medical foods are developed to address metabolic and inflammatory conditions. The Gut Sensory Modulation platform is employed to stimulate L-cell hormone release in the lower gut, influencing hunger, glucose regulation, inflammation, and mood. The primary product, Lovidia, is provided as a supplement for hunger management.
Ambra Bio's top competitors include Uute Scientific, Filament BioSolutions and WellGen.